philanthropy.org | 990 Resource | FAQ Verify yourself Sign in
BE
Person · officer / director

Benz Edward J JR MD

President and CEO Emeritus · Dana-Farber Cancer Institute INC

President and CEO Emeritus at Dana-Farber Cancer Institute INC. Listed as an officer, director, or key employee across 1 organization on the Form 990 record.

This is me
Organizations
1
Roles reported
1
Reported compensation
$1.1M

Who this is

Profile

The filed facts are verified from the IRS filings. The biography is compiled from public web sources and grounded to that filed record.

✓ Verified from filings
●
Reported as President and CEO Emeritus of Dana-Farber Cancer Institute INC, based in Boston, MA.
●
Received $1.1M in total reported compensation on the most recent Form 990 (Part VII).
Facts extracted directly from each organization's Form 990, Part VII.
Biography Web-sourced

Edward J. Benz, Jr., M.D., is President and CEO Emeritus of Dana-Farber Cancer Institute and a member of its Board of Directors.

He previously served as the Osler Professor and Chairman of the Department of Medicine at Johns Hopkins University School of Medicine (1995-2000) before leading Dana-Farber as president and CEO for 16 years. At Harvard Medical School, he holds positions as the Richard and Susan Smith Professor of Medicine, Professor of Pediatrics, and Professor of Pathology.

Compiled from public web sources (4 cited), grounded to the filed record.

Track record

Career & tenure

Real tenure, career, and education — from public web sources, what you need to vet a founder or leader beyond the filing window.

Tenure here
Dana-Farber President and CEO 2000-2016, Board Member 2017-present
Education
  • 1968) · Princeton University (A.B.1968
  • 1973) · Harvard Medical School (M.D.1973

Verify independently

Find them online

Primary links to check this person directly — their own pages, not an aggregator.

Affiliations

Organizations

Dana-Farber Cancer Institute INC President and CEO Emeritus · $2.4B revenue · Boston, MASEE SCHEDULE Opay $1.4M → $1.1MFiled FY2020, FY2019 · Source: Form 990, Part VII
$1.1Mreported comp

Network

Serves alongside

Other officers, directors & key employees at this person's organizations, by latest reported compensation.

L
President & CEO Emerita · FY2024
$2.3M
E
President CEO Emeritus · FY2021
$2.2M
G
Trustee, President and CEO · FY2020
$1.7M
W
COO & EVP · FY2024
$1.5M
M
CFO & Assistant Treasurer · FY2024
$1.2M
E
Former Key Employee · FY2023
$1.2M
M
SVP & Chief Philanthropy Officer · FY2024
$1.2M
C
Chief Medical Officer · FY2024
$1.1M
M
Professor · FY2021
$904K
R
Chief Clinical Program Officer · FY2024
$882K
C
Chief Medical Officer · FY2022
$877K
J
Asst Secretary & General Counsel · FY2024
$872K

Network

Recommendations

Written by other verified members of the network — visible once you're a verified person yourself.

Loading…

Explore

Similar organizations

Nonprofits working in the same field — explore who else operates in this space.

American Association for Cancer Research INC$129.5M revenue · Philadelphia, PA
Van Andel Research Institute$112.7M revenue · Grand Rapids, MI
The Institute for Cancer Research$94.5M revenue · Philadelphia, PA

People like this

Similar leaders

Leaders at organizations in the same field, by reported compensation.

C
Former CEO · Sanford Burnham Prebys Medical Discovery Institute
$5.0M
L
Trustee, President, and CEO · Dana-Farber Cancer Institute
$3.7M
D
VP & Chief Investment Officer · Howard Hughes Medical Institute
$3.6M
D
CEO (thru 12/31/2022) · Transcelerate Biopharma INC
$2.6M
K
President · Sanford Burnham Prebys Medical Discovery Institute
$2.6M
L
President & CEO · Jackson Laboratory
$2.5M
Public data from IRS Form 990 e-file & the Business Master File. Individuals appear here because they were named as an officer, director, or key employee on a nonprofit's Form 990; people are grouped by name plus corroborating evidence (Schedule R, shared address, shared board members). · philanthropy.org